Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis

Circulation

Volumn 98, Issue 7, 1998, Pages 628-633

  Davidson, Michael ^a,b,g   Kuo, Cho Chou ^c   Middaugh, John P ^d   Campbell, Lee Ann ^c   Wang, San Pin ^c   Newman III, William P ^e   Finley, John C ^f   Grayston, J Thomas ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ALASKA ANCHORAGE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Dept of Health and Social Services   (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALASKA NATIVE MEDICAL CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Coronary disease

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AMERICAN INDIAN; ANTIBODY TITER; ARTICLE; ATHEROMA; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0032544196     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.7.628     Document Type: Article

References (37)

1. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
2. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arteriosder Thromb. 1993;13:1501-1504.
3. Campbell LA, O'Brien ER, Cappuccio AL, Kuo C-C, Wang S-P, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Infect Dis. 1995;172:585-588.
4. Kuo C-C, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young (15-25 year) adults. Proc Natl Acad Sci USA. 1995;92:6911-6914.
5. Grayston JT, Kuo C-C, Coulson AS, Campbell LA, Lawrence RD, Lee M-J, Strandness ED, Wang S-P. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397-3400.
6. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
7. Ramirez J, and the Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979-982.
8. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-2148.
9. Jackson LA, Rodriguez DI, Lee A, Kuo C-C, Campbell LA, Grayston JT. Isolation of Chlamydia pneumoniae TWAR from a carotid plaque specimen obtained by endarterectomy. J Infect Dis. 1997;176:292-295.
10. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:48-52.
11. Saikku P, Leionen M, Mattila K, Ekman M-R, Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-985.
12. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen J, Mänttäri M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273-278.
13. Linnanmaki D, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993; 87:1130-1134.
14. Thorn DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268:68-72.
15. Thom DH, Wang S-P, Grayston JT, Siscovick DS, Stewart DK, Kronmal RA, Weiss NS. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 1991;11:547-551.
16. Puolakkainen M, Kuo C-C, Shor A, Wang S-P, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol. 1993;31:2212-2214.
17. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30:121-128.
18. Melnick SL, Shahar E, Folsom AR, Grayston JT, Wang S-P, Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95:499-504.
19. Dahlén GH, Boman J, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG, IgA, and IgM antibodies to Chlamydia pneumoniae, and HLA class II genotype in early coronary artery disease. Atherosclerosis. 1995;114: 165-174.
20. Weiss SM, Roblin P, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schacter J. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957-962.
21. Wissler RW. Significance of Chlamydia pneumoniae (TWAR) in athero-sclerotic lesions. Circulation. 1995;92:3376.
22. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996;64:1614-1620.
23. Middaugh JP. Cardiovascular deaths among Alaskan Natives, 1980-86. Am J Public Health. 1990;80:282-285.
24. Davidson M, Bulkow L, Gellin B. Cardiac mortality in Alaska's indigenous and non-Native residents. Int J Epidemiol. 1993;22:62-71.
25. Newman WP, Middaugh JP, Propst MT, Rogers DR. Atherosclerosis in Alaska Native and non-Natives. Lancet. 1993;341:1056-1057.
26. Stary HC. The evolution of human atherosclerotic lesions. West Point, Pa: Merck & Co Inc; 1993:1-84.
27. Campbell LA, Perez-Melgosa M, Hamilton DJ, Kuo C-C, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol. 1992;30:434-439.
28. Wang S-P, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Opthalmol. 1970;70:367-374.
29. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA. 1990; 264:2018-3024.
30. Kuo C-C, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 1995;8:451-461.
31. Gupta S, Leatham EW, Carrington D, Kendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
32. US Government, Alaska Area Native Health Service. Alaska Area Profile, FY 1994. Anchorage, Alaska; 1994:31.
33. Stary HC, McMillan GC. Kinetics of cellular proliferation in experimental atherosclerosis: radioautography with grain counts in cholesterol-fed rabbits. Arch Pathol. 1970;89:173-183.
34. Spring PM, Hoff HF. LDL accumulation in the grossly normal human iliac bifurcation and common iliac arteries. Exp Mol Pathol. 1989;51: 179-185.
35. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Circulation. 1992;85:391-405.
36. Altman DG, Lausen B, Sauerbrei W, Schumacher MS. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829-835.
37. Strong JP, Mcgill HC Jr. The pediatric aspects of atherosclerosis. J Atheroscler Res. 1969;9:251-265.